Duchenne News
-
Genemarker features haplotype analysis function
... of diseases such as cystic fibrosis and Duchenne muscular dystrophy. Traditionally, researchers determine the genotype of each ... today,' she added. The company offers 30-day trials and no-cost web-based training on its genetic ...
-
GSK Forms New Specialized R&D Unit
... with Patrick Vallance, senior vice president of drug discovery. The new unit will seek to ... but different, subpopulations of patients suffering from Duchenne Muscular Dystrophy (DMD). As part of the ... opportunities need to be explored to make treatments available for rare diseases. This complementary approach ...
-
AMT To Present at the BIO CEO & Investors Conference - 9th February 2010 (BIZ)
... other development programmes include: Hemophilia, Parkinson's Disease, Duchenne and Porphyria. AMT's gene therapy approach offers ... long-term (potentially lifetime) therapy from a single treatment. This could fundamentally alter treatment approaches in ...
-
AMT To Present at the BIO CEO & Investors Conference ' 9th February 2010
... other development programmes include. Hemophilia, Parkinson's Disease, Duchenne and Porphyria. AMT's gene therapy approach offers ... long-term (potentially lifetime) therapy from a single treatment. This could fundamentally alter treatment approaches in ...
-
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy
... AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation ... AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy BOTHELL, WA--(Marketwire - February 5, ... candidate being developed by AVI for the treatment of Duchenne Muscular Dystrophy (DMD). DMD is ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Researchers Report that Tò4 Increases Skeletal Muscle and May Have a Role in the Treatment of Duchenne Muscular Dystrophy
... and May Have a Role in the Treatment of Duchenne Muscular Dystrophy announced today that a research ... be important candidates as active ingredients in pharmaceutical and consumer products. Researchers at the National ...
-
Researchers Report that Tb4 Increases Skeletal Muscle and May Have a Role in the Treatment of Duchenne Muscular Dystrophy
... BETHESDA, Md.--(BUSINESS WIRE)-- REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex: ) announced today that ... Mdx mice are used as models for Duchenne muscular dystrophy to evaluate potential therapeutic compounds. ... could have a potential role in the treatment of skeletal muscle disease in Duchenne muscular ...
-
Researchers Report that Tß4 Increases Skeletal Muscle and May Have a Role in the Treatment of Duchenne Muscular Dystrophy
... Mdx mice are used as models for Duchenne muscular dystrophy to evaluate potential therapeutic compounds. ... could have a potential role in the treatment of skeletal muscle disease in Duchenne muscular ... be important candidates as active ingredients in pharmaceutical and consumer products. Researchers at the National ...
-
AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology
... Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal ... Inc. ( ), a developer of RNA-based drugs, today announced that the results and scientific ... candidate being developed by AVI for the treatment of Duchenne Muscular Dystrophy (DMD), were published ...
-
AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published
... Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that the results and scientific ... candidate being developed by AVI for the treatment of Duchenne Muscular Dystrophy (DMD), were published online in ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
AMT Receives Innovation Credit From Dutch Government for Duchenne Muscular Dystrophy
... Receives Innovation Credit From Dutch Government for Duchenne Muscular Dystrophy AMSTERDAM, January 6/PRNewswire-FirstCall/ -- Amsterdam ... support the development of AMT's gene therapy treatment for Duchenne Muscular Dystrophy (DMD). The credit ... European Medicines Evaluation Agency (EMEA) granted Orphan Drug Designation to AMT's gene therapy product AMT-080 ...
-
Researchers Report that TÃ4 Increases Skeletal Muscle and May Have a Role in the Treatment of Duchenne Muscular Dystrophy
... About RegeneRx Biopharmaceuticals, Inc. RegeneRx is focused on the discovery ... has now completed a Phase I clinical trial supporting delivery of RGN-352 for acute cardiovascular ... and RGN-352, including in diseases such as Duchenne muscular dystrophy. Further, the Company's product candidates ...
-
Tβ4 may help treat skeletal muscle disease in Duchenne muscular dystrophy
... Mdx mice are used as models for Duchenne to evaluate potential therapeutic compounds. According to ... could have a potential role in the treatment of skeletal muscle disease in Duchenne . ... Molecular Biology at the George Washington University Medical Center, Washington, DC, and RegeneRxs chief scientific ...
-
Researchers Report that Tβ4 Increases Skeletal Muscle and May Have a Role in the Treatment of Duchenne Muscular Dystrophy
...
-
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscu
... AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation ... AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy AVI BioPharma's Drug Candidate AVI-5038 ... candidate being developed by AVI for the treatment of Duchenne Muscular Dystrophy (DMD). DMD is ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
Related newsletters
Search
Presswire
Press Release Distribution Service
- US Justice Department Rejects Google Book Settlement [09 Feb 2010]
- Housing Prices Moving North in Canada [09 Feb 2010]
- Colorado Geothermal Land Lease Delayed for Third Time [09 Feb 2010]
News publications
- World News Report
- US Politics Today
- EU Politics Today
- Healthcare Industry Today
- Music Industry Today
- Agriculture Industry Today
- Energy Industry Today
- IT Industry Today
- Airline Industry Today
- Automotive Industry Today
- Finance Industry Today
© 2005-2010